ALHC Alignment Healthcare, Inc.
Hospital & Medical Service Plans · Nasdaq · SEC CIK 1832466 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.36B | $1.34B | $1.24B | $1.01B | $993.70M | $1.02B | $926.93M | $701.24M |
| SG&A expense | $136.37M | $131.00M | $121.14M | $125.76M | $110.02M | $103.80M | $103.83M | $102.13M |
| Operating income | -$3.79M | $42.10M | $15.50M | -$10.28M | $7.68M | $22.75M | -$5.39M | -$22.55M |
| Interest expense | $4.28M | $4.28M | $4.06M | $3.95M | $3.95M | $3.95M | $3.95M | $5.49M |
| Pretax income | -$8.07M | $37.83M | $11.44M | -$14.23M | $3.73M | $18.88M | -$9.33M | -$31.06M |
| Income tax | -$22,000 | $1.27M | $25,000 | -$3.23M | $2,000 | $3.22M | $21,000 | $7,000 |
| Net income | -$8.05M | $36.56M | $11.42M | -$11.01M | $3.73M | $15.67M | -$9.11M | -$31.09M |
| EBITDA | $4.31M | $49.95M | $23.34M | -$2.45M | $15.66M | $29.75M | $2.20M | -$15.78M |
| EPS (basic) | -0.04 | 0.18 | 0.06 | — | 0.02 | 0.08 | -0.05 | — |
| EPS (diluted) | -0.04 | 0.17 | 0.05 | — | 0.02 | 0.07 | -0.05 | — |
| Weighted avg. shares (diluted) | 208.56M | 215.02M | 213.13M | — | 208.93M | 209.52M | 193.61M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $727.69M | $693.45M | $705.58M | $575.82M | $618.07M | $470.27M | $446.18M | $434.94M |
| Short-term investments | $15.26M | $8.26M | $20.71M | $28.41M | $26.01M | $33.51M | $33.36M | $37.79M |
| Receivables | $242.54M | $296.89M | $277.68M | $253.21M | $219.84M | $282.93M | $214.06M | $153.90M |
| Current assets | $1.18B | $1.16B | $1.15B | $951.58M | $985.32M | $880.12M | $774.49M | $661.64M |
| PP&E, net | $66.44M | $66.21M | $63.87M | $64.25M | $67.02M | $69.52M | $68.50M | $67.14M |
| Goodwill | $32.06M | $32.06M | $32.06M | $32.06M | $32.06M | $32.06M | $34.19M | $34.83M |
| Intangibles | $4.55M | $4.55M | $4.55M | $4.55M | $4.55M | $4.55M | $4.55M | $4.55M |
| Total assets | $1.30B | $1.28B | $1.26B | $1.07B | $1.10B | $1.00B | $895.62M | $782.06M |
| Current liabilities | $689.05M | $683.41M | $724.76M | $556.87M | $611.09M | $529.53M | $457.12M | $351.85M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $324.50M | $324.06M | $323.62M | $323.18M | $322.74M | $322.30M | $321.86M | $321.43M |
| Total debt | $324.50M | $324.06M | $323.62M | $323.18M | $322.74M | $322.30M | $321.86M | $321.43M |
| Total liabilities | $1.02B | $1.01B | $1.05B | $886.51M | $940.74M | $859.18M | $786.62M | $681.11M |
| Shareholders' equity | $277.11M | $265.13M | $206.88M | $179.28M | $161.87M | $140.97M | $108.13M | $99.85M |
| Net debt | -$403.20M | -$369.40M | -$381.97M | -$252.64M | -$295.33M | -$147.97M | -$124.33M | -$113.51M |
| Shares outstanding | 209.15M | 207.18M | 206.67M | 204.15M | 199.99M | 197.96M | 197.67M | 191.78M |
| Cash flow statement | ||||||||
| Operating cash flow | $47.03M | -$17.31M | $128.68M | -$50.38M | $144.56M | $29.13M | $16.62M | -$8.71M |
| Capital expenditure | $8.44M | $10.14M | $7.36M | $5.03M | $5.50M | $8.00M | $8.25M | $9.28M |
| Free cash flow | $38.58M | -$27.46M | $121.32M | -$55.40M | $139.06M | $21.13M | $8.36M | -$18.00M |
| Investing cash flow | -$15.32M | $2.42M | $578,000 | -$7.16M | $2.31M | -$6.66M | -$3.46M | -$5.92M |
| Financing cash flow | $2.55M | $2.77M | $515,000 | $15.30M | $948,000 | $1.62M | $181,000 | $106.88M |
| Depreciation & amortization | $8.11M | $7.85M | $7.84M | $7.83M | $7.98M | $7.00M | $7.59M | $6.76M |
| Stock-based compensation | $17.49M | $18.17M | $14.02M | $13.12M | $16.23M | $15.55M | $17.19M | $16.24M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.